-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of albuminuria due to diabetic nephropathy: recent trial results
Edward J Horwitz & Jeffrey R Schelling
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation
-
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Clinical Trail Outcomes: Clinical Investigation